Trump's $500M Flu Shot Grant

This is a news story, published by KFF Health News, that relates primarily to Jeffery Taubenberger news.

Jeffery Taubenberger news

For more Jeffery Taubenberger news, you can click here:

more Jeffery Taubenberger news

News about vaccine development

For more vaccine development news, you can click here:

more vaccine development news

KFF Health News news

For more news from KFF Health News, you can click here:

more news from KFF Health News

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about

vaccine fund

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pandemic vaccine news, candidate vaccine news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

flu vaccine consortium

KFF Health News

•

Health

Trump’s $500 million grant for a broadly protective flu shot has baffled vaccine experts

Summary

Nutrition label

83% Informative

The $500 million grant for a broadly protective flu shot has confounded vaccine and pandemic preparedness experts.

Experts say the project was in early stages, relied on old technology, and was just one of more than 200 such efforts.

The vaccine is being developed at the National Institute for Allergy and Infectious Diseases by Jeffery Taubenberger and Matthew Memoli .

NIH involvement through more stages of development could give the government greater influence on vaccine's eventual price.

Vaccine is made by inactivating influenza viruses with a carcinogenic chemical called beta-propiolactone.

Scientists are testing the vaccine as a regular shot and as an intranasal spray with the idea of stopping virus in respiratory tract before it causes a broad infection.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful